Samuel Wilkinson, MD, associate professor of psychiatry, and Greg Rhee, PhD, assistant professor adjunct of psychiatry, have been awarded $2.15 million from the National Institute of Health to study the longitudinal effects of ECT as a treatment for “neuropsychiatric symptoms” of Alzheimer’s disease and related dementia. The release from Yale Medical School doesn’t explain how the researchers will obtain consent from those with severe dementia to participate in their study.
***
Back to Around the Web